# Effect of PreforPro® on Urinary and Vaginal Health

> **NCT05590195** · PHASE3 · UNKNOWN · sponsor: **Jeremy Burton** · enrollment: 50 (estimated)

## Conditions studied

- Bacterial Vaginosis
- Bacterial Infections
- Bacterial Vaginosis | Vaginal | Microbiology
- Vaginal Infection

## Interventions

- **DRUG:** Preforpro
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05590195
- **Lead sponsor:** Jeremy Burton
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590195, "Effect of PreforPro® on Urinary and Vaginal Health". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05590195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*